Two outcomes from one immune attack
Autoimmune endocrine disease happens when the immune system stops recognizing a gland as self. The remarkable thing is that this can produce either deficiency or excess. If the attack destroys hormone-making cells, you get deficiency. If, instead, an antibody happens to bind a receptor and activate it, you get unregulated excess. The thyroid shows both faces beautifully.
In Hashimoto's thyroiditis, lymphocytes infiltrate the gland and gradually destroy follicular cells, so T4 falls and TSH climbs — classic primary deficiency. In Graves' disease, an antibody mimics TSH by binding and stimulating the TSH receptor; the gland is driven hard, T4 soars, and TSH is suppressed — classic excess, but from the immune system, not a tumor.
When several glands fail together
Autoimmunity rarely respects organ borders. The same person prone to one autoimmune gland is at risk for others, because the underlying tolerance defect is systemic. Type 1 diabetes destroys the beta cells; Addison's disease destroys the adrenal cortex; Hashimoto's takes the thyroid. When two or more cluster in one patient, you're looking at an autoimmune polyendocrine syndrome.
- Spot one autoimmune endocrine diagnosis — then actively screen for the common companions.
- Order organ-specific antibodies and the relevant gland hormone with its tropic partner.
- Remember the danger pair: untreated adrenal failure plus a thyroid problem can be life-threatening if thyroid hormone is started first.
How treatment follows the mechanism
Because autoimmune destruction is usually permanent, deficiency states are managed by replacing the missing hormone for life — levothyroxine for Hashimoto's, insulin for type 1 diabetes, glucocorticoid (and often mineralocorticoid) for Addison's. The stimulating-antibody excess of Graves' is different: here you dial the gland down with an antithyroid drug, radioiodine, or surgery, because removing the source of hormone is what breaks the loop.